Cyclic Dichalcogenides Extend the Reach of Bioreductive Prodrugs to Harness Thiol/Disulfide Oxidoreductases: Applications to


Journal

ACS central science
ISSN: 2374-7943
Titre abrégé: ACS Cent Sci
Pays: United States
ID NLM: 101660035

Informations de publication

Date de publication:
26 Apr 2023
Historique:
received: 08 12 2022
medline: 1 5 2023
pubmed: 1 5 2023
entrez: 1 5 2023
Statut: epublish

Résumé

Small-molecule prodrug approaches that can activate cancer therapeutics selectively in tumors are urgently needed. Here, we developed the first antitumor prodrugs designed for activation by thiol-manifold oxidoreductases, targeting the thioredoxin (Trx) system. The Trx system is a critical cellular redox axis that is tightly linked to dysregulated redox/metabolic states in cancer, yet it cannot be addressed by current bioreductive prodrugs, which mainly cluster around oxidized nitrogen species. We instead harnessed Trx/TrxR-specific artificial dichalcogenides to gate the bioactivity of 10 "off-to-on" reduction-activated duocarmycin prodrugs. The prodrugs were tested for cell-free and cellular reductase-dependent activity in 177 cell lines, establishing broad trends for redox-based cellular bioactivity of the dichalcogenides. They were well tolerated

Identifiants

pubmed: 37122469
doi: 10.1021/acscentsci.2c01465
pmc: PMC10141580
doi:

Types de publication

Journal Article

Langues

eng

Pagination

763-776

Informations de copyright

© 2023 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare the following competing financial interest(s): J.G.F., L.Z., J.T.-S. and O.T.-S. are inventors on patent applications PCT/EP2022/057483 and PCT/EP2022/059280 filed by the Ludwig-Maximilians-University (LMU) Munich in 2021, covering compound structures reported in this paper.

Références

BMC Cancer. 2012 Oct 25;12:496
pubmed: 23098625
Clin Transl Radiat Oncol. 2019 Jan 18;15:62-69
pubmed: 30734002
J Am Chem Soc. 2019 Jan 16;141(2):981-989
pubmed: 30562459
Eur J Med Chem. 2010 Feb;45(2):752-9
pubmed: 19954866
Curr Opin Pharmacol. 2007 Aug;7(4):392-7
pubmed: 17611157
Cancer Invest. 1986;4(1):15-23
pubmed: 3754176
J Biol Chem. 2012 Nov 2;287(45):38210-9
pubmed: 22977247
Cancer Res. 1992 Sep 15;52(18):4904-13
pubmed: 1516047
Clin Cancer Res. 2012 Feb 1;18(3):758-70
pubmed: 22184053
Bioorg Med Chem. 1994 Feb;2(2):115-35
pubmed: 7922122
Chem. 2022 May 12;8(5):1493-1517
pubmed: 35936029
J Med Chem. 2005 Jun 2;48(11):3903-18
pubmed: 15916443
Jpn J Cancer Res. 1994 Apr;85(4):418-25
pubmed: 8200853
Br J Cancer. 1984 Feb;49(2):215-23
pubmed: 6696822
J Am Chem Soc. 2021 Jun 16;143(23):8791-8803
pubmed: 34061528
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2
pubmed: 18432775
Bioorg Med Chem. 2016 Nov 15;24(22):6075-6081
pubmed: 27745990
J Med Chem. 2005 Jul 28;48(15):4772-82
pubmed: 16033257
J Pharmacol Exp Ther. 2005 Jun;313(3):1011-6
pubmed: 15687373
Angew Chem Int Ed Engl. 2006 Oct 6;45(39):6574-7
pubmed: 16960905
Nat Commun. 2022 Apr 1;13(1):1754
pubmed: 35365603
Cancer Res. 2010 Nov 15;70(22):9505-14
pubmed: 21045148
Bioorg Med Chem Lett. 2006 Oct 15;16(20):5350-5
pubmed: 16901694
Pancreas. 2010 May;39(4):425-35
pubmed: 20418756
Bioorg Med Chem. 1995 Nov;3(11):1429-53
pubmed: 8634824
J Am Chem Soc. 2007 Dec 12;129(49):15391-7
pubmed: 18020335
Methods Mol Med. 2004;90:515-42
pubmed: 14657582
JACS Au. 2022 Nov 15;2(12):2636-2644
pubmed: 36590260
Angew Chem Int Ed Engl. 2010 Sep 24;49(40):7336-9
pubmed: 20799305
Biosci Rep. 2015 Jun 12;35(4):
pubmed: 26182432
Nat Rev Cancer. 2006 Oct;6(10):813-23
pubmed: 16990858
Angew Chem Int Ed Engl. 2018 May 22;57(21):6141-6145
pubmed: 29582524
J Pharm Sci. 1963 Sep;52:852-7
pubmed: 14061044
Bioorg Med Chem. 2006 Dec 1;14(23):7854-61
pubmed: 16908174
J Med Chem. 2008 Nov 13;51(21):6853-65
pubmed: 18847185
Angew Chem Int Ed Engl. 2011 Mar 7;50(11):2606-9
pubmed: 21370347
J Med Chem. 1999 Aug 26;42(17):3400-11
pubmed: 10464026
Br J Pharmacol. 2013 Jan;168(1):11-8
pubmed: 22509926
Bioorg Med Chem. 1996 Aug;4(8):1379-91
pubmed: 8879561
Cancer Res. 1982 Mar;42(3):999-1004
pubmed: 6174220
Biochem Biophys Res Commun. 2010 May 21;396(1):120-4
pubmed: 20494123

Auteurs

Jan G Felber (JG)

Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Annabel Kitowski (A)

Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Lukas Zeisel (L)

Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Martin S Maier (MS)

Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Constanze Heise (C)

Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Julia Thorn-Seshold (J)

Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Oliver Thorn-Seshold (O)

Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Classifications MeSH